1,688
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Combined antibacterial and osteogenic in situ effects of a bifunctional titanium alloy with nanoscale hydroxyapatite coating

, , , , , , & show all
Pages 460-470 | Received 07 Jun 2018, Accepted 06 Jul 2018, Published online: 27 Sep 2018

Figures & data

Figure 1. A bifunctional titanium alloy with a nano-hydroxyapatite coating (HBD + BMP/HA-Ti), which enables the simultaneously sustained release of the natural antimicrobial peptide human β-defensin 3 (HBD-3) and bone morphogenetic protein-2 (BMP-2). It shows combined antibacterial and osteogenic effects for potential application in clinical dental and bone therapy.

Figure 1. A bifunctional titanium alloy with a nano-hydroxyapatite coating (HBD + BMP/HA-Ti), which enables the simultaneously sustained release of the natural antimicrobial peptide human β-defensin 3 (HBD-3) and bone morphogenetic protein-2 (BMP-2). It shows combined antibacterial and osteogenic effects for potential application in clinical dental and bone therapy.

Figure 2. Preparation and structure of the bifunctional titanium alloy HBD + BMP/HA-Ti. (A) Schematic of the preparation procedure of HBD + BMP/HA-Ti. S1,S2: the Ti substrate was modified using preformed HA particles (HA) to form a poriferous nano-HA coating. S3: adsorption of antimicrobial HBD-3 and BMP-2. S4: slow combined release of HBD-3 and BMP-2; bifunctionality of HBD + BMP/HA-Ti, including antimicrobial activity and induction of osteogenic differentiation. (B) Appearance of the Ti, HA-Ti, and HBD + BMP/HA-Ti materials.

Figure 2. Preparation and structure of the bifunctional titanium alloy HBD + BMP/HA-Ti. (A) Schematic of the preparation procedure of HBD + BMP/HA-Ti. S1,S2: the Ti substrate was modified using preformed HA particles (HA) to form a poriferous nano-HA coating. S3: adsorption of antimicrobial HBD-3 and BMP-2. S4: slow combined release of HBD-3 and BMP-2; bifunctionality of HBD + BMP/HA-Ti, including antimicrobial activity and induction of osteogenic differentiation. (B) Appearance of the Ti, HA-Ti, and HBD + BMP/HA-Ti materials.

Table 1. The encapsulation efficiency (EE) of samples loaded with HBD-3 and BMP-2.

Figure 3. SEM micrographs and slow-release test. (A–D) SEM micrographs showing the poriferous HA coating of HBD + BMP/HA-Ti (B and C), a section with a thickness of 20–30 μm (D), and the smooth surface of Ti (B). (B) Cumulative release curve of HBD-3 and BMP-2.

Figure 3. SEM micrographs and slow-release test. (A–D) SEM micrographs showing the poriferous HA coating of HBD + BMP/HA-Ti (B and C), a section with a thickness of 20–30 μm (D), and the smooth surface of Ti (B). (B) Cumulative release curve of HBD-3 and BMP-2.

Figure 4. Test of the antibacterial properties of the coatings. (A) Comparison of the Ti specimens’ antibacterial capacity against suspensions of E. coli or S. aureus after culture for 1 and 7 days. (B) The optical density at 600 nm (O.D(0).600) of the bacterial suspensions. Each measurement was conducted with 3 parallel samples. ***p < .005.

Figure 4. Test of the antibacterial properties of the coatings. (A) Comparison of the Ti specimens’ antibacterial capacity against suspensions of E. coli or S. aureus after culture for 1 and 7 days. (B) The optical density at 600 nm (O.D(0).600) of the bacterial suspensions. Each measurement was conducted with 3 parallel samples. ***p < .005.

Figure 5. Determination of the viability of adherent bacteria on the Ti specimens. (A) CLSM image of bacteria grown on the Ti specimens immersed in the bacterial suspension after culture for 1 and 7 days. The amount and distribution of living (green) and dead (red) bacterial cells as determined using the Live/Dead BacLight Bacterial Viability Kit. (B) Quantification of living bacteria grown on the Ti specimens using FDA measurement at days 1 and 7. Each sample was measured in triplicate. *p < .05, **p < .01, ***p < .005. (C) SEM images of the bacterial grown on Ti specimens immersed in the bacterial suspension after culture for 7 days. The dead and damaged bacterial cells that were observed on HBD/HA-Ti and HBD + BMP/HA-Ti are indicated with red arrows.

Figure 5. Determination of the viability of adherent bacteria on the Ti specimens. (A) CLSM image of bacteria grown on the Ti specimens immersed in the bacterial suspension after culture for 1 and 7 days. The amount and distribution of living (green) and dead (red) bacterial cells as determined using the Live/Dead BacLight Bacterial Viability Kit. (B) Quantification of living bacteria grown on the Ti specimens using FDA measurement at days 1 and 7. Each sample was measured in triplicate. *p < .05, **p < .01, ***p < .005. (C) SEM images of the bacterial grown on Ti specimens immersed in the bacterial suspension after culture for 7 days. The dead and damaged bacterial cells that were observed on HBD/HA-Ti and HBD + BMP/HA-Ti are indicated with red arrows.

Figure 6. Cell proliferation of hBMSCs grown on the Ti specimens. (A) CLSM images of hBMSCs grown on Ti specimens at day 7. (B) Quantification of the hBMSCs growing on the Ti specimens by CCK-8 measurements at days 1, 4, and 7. Each measurement contained 6 parallel samples. n.s. = no significant difference, *p < .05. (C) SEM images of hBMSCs growing on Ti specimens at day 7.

Figure 6. Cell proliferation of hBMSCs grown on the Ti specimens. (A) CLSM images of hBMSCs grown on Ti specimens at day 7. (B) Quantification of the hBMSCs growing on the Ti specimens by CCK-8 measurements at days 1, 4, and 7. Each measurement contained 6 parallel samples. n.s. = no significant difference, *p < .05. (C) SEM images of hBMSCs growing on Ti specimens at day 7.

Figure 7. Osteoinductive differentiation of hBMSCs grown on the Ti specimens. (A) CLSM images showing the expression of COL-1 by the hBMSCs grown on the Ti specimens at day 7. (B) ALP activity of hBMSCs grown on the Ti specimens at days 1, 4, and 7. (C) Quantitative PCR analysis of the expression of osteogenic gene markers in hBMSCs cultured on Ti specimens at day 1. The y-axis represents the relative expression (2-ΔCT) normalized to the expression level of the housekeeping gene GAPDH. Each measurement was done on 3 samples. n.s. = no significant difference, **p < .01, ***p < .005.

Figure 7. Osteoinductive differentiation of hBMSCs grown on the Ti specimens. (A) CLSM images showing the expression of COL-1 by the hBMSCs grown on the Ti specimens at day 7. (B) ALP activity of hBMSCs grown on the Ti specimens at days 1, 4, and 7. (C) Quantitative PCR analysis of the expression of osteogenic gene markers in hBMSCs cultured on Ti specimens at day 1. The y-axis represents the relative expression (2-ΔCT) normalized to the expression level of the housekeeping gene GAPDH. Each measurement was done on 3 samples. n.s. = no significant difference, **p < .01, ***p < .005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.